Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Oct 1;49(10):1844-1847.
doi: 10.1097/CCM.0000000000005121.

New Ways to Skin a Cat or Still a Cat Chasing Its Tail? Bayesian Vancomycin Monitoring in the ICU

Affiliations
Editorial

New Ways to Skin a Cat or Still a Cat Chasing Its Tail? Bayesian Vancomycin Monitoring in the ICU

Alexander H Flannery et al. Crit Care Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report receiving grant support from the American College of Clinical Pharmacy Foundation to study Bayesian vancomycin monitoring. Dr. Flannery’s institution received funding from the American College of Clinical Pharmacy Foundation. Dr. Landmesser received funding from the American College of Clinical Pharmacy Foundation. Dr. Mynatt has disclosed that he does not have any potential conflicts of interest.

Comment on

References

    1. Kelesidis T, Braykov N, Uslan DZ, et al.: Indications and types of antibiotic agents used in 6 acute care hospitals, 2009-2010: A Pragmatic Retrospective Observational Study. Infect Control Hosp Epidemiol. 2016; 37:70–79
    1. Blot SI, Pea F, Lipman J: The effect of pathophysiology on pharmacokinetics in the critically ill patient–concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev. 2014; 77:3–11
    1. Pai MP, Neely M, Rodvold KA, et al.: Innovative approaches to optimizing the delivery of vancomycin in individual patients. Adv Drug Deliv Rev. 2014; 77:50–57
    1. Rybak MJ, Le J, Lodise TP, et al.: Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020; 77:835–864
    1. Narayan SW, Thoma Y, Drennan PG, et al.: Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill. Crit Care Med. 2021; 49:e952–e960

LinkOut - more resources